⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6982135 | 1.00 | — | — | |
| SCHEMBL26000644 | 0.70 | — | — | |
| SCHEMBL15934225 | 0.70 | — | — | |
| SCHEMBL31664985 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL18226410 | 0.69 | — | — | |
| SCHEMBL16219883 | 0.69 | — | — | |
| SCHEMBL23605165 | 0.65 | — | — | |
| SCHEMBL10264143 | 0.65 | — | — | |
| SCHEMBL7614249 | 0.65 | — | — | |
| SCHEMBL20748213 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109154604-A | Charged surface reverse phase chromatography material method for analysis of glycans modified with amphiphilic strongly basic moieties | 沃特世科技公司 | 2019-01-04 | — | — | CN | claimed |
| US-7541123-B2 | Imaging member | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | claimed |
| US-20060284194-A1 | Imaging member | XEROX CORPORATION | 2006-12-21 | — | — | US | claimed |
| EP-0603887-B1 | Bicyclic amine derivatives | DAIICHI SEIYAKU CO (JP) | 2003-10-01 | — | — | EP | claimed |
| EP-0603887-A2 | Bicyclic amine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1994-06-29 | — | — | EP | claimed |
| CN-107921818-B | With the modified diene elastomer for reducing PDI and include its composition | 米其林集团总公司 | 2019-11-26 | — | — | CN | disclosed |
| CN-110114228-A | Tire tread comprising modified elastomer | 米其林集团总公司 | 2019-08-09 | — | — | CN | disclosed |
| CN-110099804-A | Rubber composition including modified diene elastomer | 米其林集团总公司 | 2019-08-06 | — | — | CN | disclosed |
| CN-109937147-A | Tire including tyre surface | 米其林集团总公司 | 2019-06-25 | — | — | CN | disclosed |
| CN-108136828-A | In the middle part of chain there is the diene elastomer of functional group and include its rubber composition | 米其林集团总公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-108136827-A | Include the rubber composition of the diene elastomer in the middle part of chain with functional group | 米其林集团总公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-107921818-A | With the modified diene elastomer for reducing PDI and include its composition | 米其林集团总公司 | 2018-04-17 | — | — | CN | disclosed |
| US-6133260-A | Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases | BAYER AKTIENGESELLSCHAFT (DE) | 2000-10-17 | — | — | US | disclosed |
| US-6133260-A | Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases | BAYER AKTIENGESELLSCHAFT (DE) | 2000-10-17 | — | — | US | disclosed |
| CN-1245428-A | Use of 7- (2-oxa-5, 8-diazabicyclo [4.3.0] non-8-yl) quinolone-and naphthyridonecarboxylic acid derivatives for the treatment of helicobacter pylori infections and gastroduodenal diseases associated therewith | BAYER AG (DE) | 2000-02-23 | — | — | CN | disclosed |
| EP-0946176-A1 | THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES | BAYER AG (DE) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998026779-A1 | THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO[4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-25 | — | — | WO | disclosed |
| US-5654318-A | 1-HALOCYCLOPROPYL-3-CARBOXY-4-OXO-7-(2,8-DIAZOBICYCLO(4.3.0)-NON-8-YL)QUINOLINES; POTENT MICROBIOCIDES; NONTOXIC; REDUCED LIPOPHILICITY | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1997-08-05 | — | — | US | disclosed |
| EP-0603887-A2 | Bicyclic amine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1994-06-29 | — | — | EP | disclosed |
| EP-0428803-A1 | Novel ligand catalyst systems formed by reaction of carbonyl compounds with organosilicon compounds | TEXACO DEVELOPMENT CORPORATION (US) | 1991-05-29 | — | — | EP | disclosed |